CGBio gets FDA approval for Novosis Putty

South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...

S.Korea's CGBio gets FDA approval for spinal implant

CGBio, a South Korean bio-regenerative medical company, announced on Monday that its "Advanced LumFix spinal fixation system," an implant and surgic...

S.Korea's CGBio exports $8 mn filler to Australia, New Zealand

CGBio, a South Korean bio-regenerative medical company, announced on Thursday that it has signed a contract to export its hyaluronic acid (HA) fille...

CGBio inks export deal for hyaluronic acid fillers with Chinese distributor

CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distri...

CGBio opens cosmetic surgery clinic in Bali using bio-medical tech

CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...